Insulet Q1 revenue $761.7M (+33.9%), beats guidance; raises FY revenue outlook

INSULET CORP

2026-Q1 EPS reported $1.30 revenue$761,700,000

Q1 revenue $761.7M, up 33.9% YoY (30.1% constant currency), exceeding guidance range of 25-27% constant currency.
GAAP diluted EPS $1.30 vs $0.50 prior year; adjusted EPS $1.42 vs $1.02.
U.S. Omnipod revenue $515.6M (+28.3%); International $242.9M (+59.4%, +45.2% constant currency).
Adjusted operating income margin 17.5% (up 110 bps YoY); net income $91.1M vs $35.4M.
Launched Omnipod 5 algorithm update with new 100 mg/dL target; limited market release with FreeStyle Libre 3 Plus.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

INSULET CORP reported first quarter ended March 31, 2026 results: revenue $761.7 million, net income $91.1 million, or $1.30 per diluted share, EPS $1.30 per diluted share. Guidance raised.

Period: first quarter ended March 31, 2026
Revenue: $761.7 million
Net income: $91.1 million, or $1.30 per diluted share
EPS: $1.30 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

with its Omnipod ® brand of products, today announced its financial results for the three months ended March 31, 2026. First Quarter Financial Highlights: • Revenue of $761.7 million, up 33.9%, or 30.1% in constant currency 1 , and exceeded the high end of the Company’s guidance range of 25% - 27% at constant currency rates ◦ Total Omnipod revenue of $758.4

View on SEC.gov

Browse all earnings releases →

INSULET CORP filing history →

Source: SEC EDGAR

accession 0001145197-26-000100

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.